InvestorsHub Logo
Followers 9
Posts 567
Boards Moderated 0
Alias Born 02/07/2020

Re: Pinseekr post# 216504

Wednesday, 01/11/2023 5:04:57 PM

Wednesday, January 11, 2023 5:04:57 PM

Post# of 232585
Or you could say the FDA new that LL did perform much better than SOC for first and second week! That they limited the doses to 2 weeks instead of the four week dosage we requested. Well obviously the effectiveness dropped off the last two weeks and cd12 failed. In the “hit piece” letter from the FDA (unsigned) they didn’t say the data Nader quoted was wrong 78% and 82% better than SOC for week one and two. They said it was “cherry picked”! Ok, you could say that. But after seeing the data after the first two weeks and zero dosage the last two weeks do you think the FDA might be excited that there might be something to cd12 and want to dig a little deeper?? They were not the slightest bit interested. The first two weeks was so troubling and possible impede the future “vaccine” mandates so a “Hit Piece” letter was necessary. Can’t prove it, but makes sense to me. The trial was over. LL failed. Again why did the FDA feel so threatened that a hit piece letter would be necessary.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News